Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele

[1]  Nick C Fox,et al.  Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease , 2011, Neurobiology of Aging.

[2]  J. Stockman,et al.  Longitudinal Modeling of Age-Related Memory Decline and the APOE ɛ4 Effect , 2011 .

[3]  David A Wolk,et al.  Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  David A Wolk,et al.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease , 2010, Proceedings of the National Academy of Sciences.

[5]  W. M. van der Flier,et al.  Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. , 2010, Clinical chemistry.

[6]  M. Weiner,et al.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. , 2010, Brain : a journal of neurology.

[7]  Wiesje M van der Flier,et al.  Early-versus late-onset Alzheimer's disease: more than age alone. , 2010, Journal of Alzheimer's disease : JAD.

[8]  G. Alexander,et al.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. , 2009, The New England journal of medicine.

[9]  Wiesje M. van der Flier,et al.  CSF biomarker levels in early and late onset Alzheimer's disease , 2009, Neurobiology of Aging.

[10]  Nick C. Fox,et al.  Patterns of Cortical Thickness according to APOE Genotype in Alzheimer’s Disease , 2009, Dementia and Geriatric Cognitive Disorders.

[11]  B. Miller,et al.  Clinical syndromes associated with posterior atrophy , 2009, Neurology.

[12]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[13]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[14]  Philip Scheltens,et al.  Dementia: the bare essentials. , 2009, Practical neurology.

[15]  W. M. van der Flier,et al.  CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. , 2009, JAMA.

[16]  Paul M. Thompson,et al.  Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo , 2009, NeuroImage.

[17]  K. Blennow,et al.  The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease , 2009, Neurobiology of Aging.

[18]  M Schwaiger,et al.  Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease , 2009, Neurology.

[19]  W. M. van der Flier,et al.  Most rapid cognitive decline in APOE ε4 negative Alzheimer's disease with early onset , 2009, Psychological Medicine.

[20]  Thomas E. Nichols,et al.  Anatomically-distinct genetic associations of APOE ɛ4 allele load with regional cortical atrophy in Alzheimer's disease , 2009, NeuroImage.

[21]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[22]  W. M. van der Flier,et al.  CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age. , 2009, Journal of Alzheimer's disease : JAD.

[23]  J R Hodges,et al.  Incidence of early-onset dementias in Cambridgeshire, United Kingdom , 2008, Neurology.

[24]  R. Katzman.,et al.  The Prevalence and Malignancy of Alzheimer Disease A Major Killer , 2008, Alzheimer's & Dementia.

[25]  S. Morikawa,et al.  Different Atrophic Patterns in Early- and Late-Onset Alzheimer’s Disease and Evaluation of Clinical Utility of a Method of Regional z-Score Analysis Using Voxel-Based Morphometry , 2008, Dementia and Geriatric Cognitive Disorders.

[26]  W. M. van der Flier,et al.  Early-Onset Dementia Is Associated with Higher Mortality , 2008, Dementia and Geriatric Cognitive Disorders.

[27]  Nick C Fox,et al.  Whole-brain atrophy rate in Alzheimer disease , 2008, Neurology.

[28]  Julie S. Snowden,et al.  Cognitive Phenotypes in Alzheimer's Disease and Genetic Risk , 2007, Cortex.

[29]  S. Sorbi,et al.  Pattern and Progression of Cognitive Decline in Alzheimer’s Disease: Role of Premorbid Intelligence and ApoE Genotype , 2007, Dementia and Geriatric Cognitive Disorders.

[30]  Martin Klein,et al.  Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study , 2007, Neuroradiology.

[31]  K Patterson,et al.  Focal cortical presentations of Alzheimer's disease. , 2007, Brain : a journal of neurology.

[32]  Shunichiro Shinagawa,et al.  Comparison of behavioral and psychological symptoms in early‐onset and late‐onset Alzheimer's disease , 2007, International journal of geriatric psychiatry.

[33]  Martin Klein,et al.  Cognitive Impairment in Alzheimer’s Disease Is Modified by APOE Genotype , 2007, Dementia and Geriatric Cognitive Disorders.

[34]  J. Cummings,et al.  Early-Onset Alzheimer’s Disease Is Associated With Greater Pathologic Burden , 2007, Journal of geriatric psychiatry and neurology.

[35]  Kiralee M. Hayashi,et al.  The topography of grey matter involvement in early and late onset Alzheimer's disease. , 2007, Brain : a journal of neurology.

[36]  Exploded drawing in posterior cortical atrophy , 2006, Neurology.

[37]  D. Neary,et al.  Apolipoprotein E ε4 Allele Frequency and Age at Onset of Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[38]  W. M. van der Flier,et al.  Apolipoprotein E Genotype Influences Presence and Severity of Delusions and Aggressive Behavior in Alzheimer Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[39]  Masayuki Matsuda,et al.  Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease , 2006, NeuroImage.

[40]  P. Lucassen,et al.  Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus , 2006, Neurobiology of Disease.

[41]  Nick C Fox,et al.  The effect of APOE genotype on clinical phenotype in Alzheimer disease , 2006, Neurology.

[42]  Ge Li,et al.  Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. , 2006, Archives of neurology.

[43]  M. Macavoy,et al.  Apolipoprotein E ε4 Allele Is Unrelated to Cognitive or Functional Decline in Alzheimer’s Disease: Retrospective and Prospective Analysis , 2006, Dementia and Geriatric Cognitive Disorders.

[44]  W. M. van der Flier,et al.  Hippocampal atrophy in Alzheimer disease: Age matters , 2006, Neurology.

[45]  Nick C Fox,et al.  Apolipoprotein e genotype modifies the phenotype of Alzheimer disease. , 2006, Archives of neurology.

[46]  C. D. de Jager,et al.  APOE alleles predict the rate of cognitive decline in Alzheimer disease , 2005, Neurology.

[47]  S. I. Lee,et al.  APOE ε2/ε4 polymorphism and cerebral microbleeds on gradient-echo MRI , 2005, Neurology.

[48]  Hilkka Soininen,et al.  Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers , 2005, Annals of neurology.

[49]  Sue J. Kang,et al.  Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. , 2005, Brain : a journal of neurology.

[50]  P. Matthews,et al.  Risk factors for progression of brain atrophy in aging , 2005, Neurology.

[51]  S. DeKosky,et al.  Alzheimer disease and mortality: a 15-year epidemiological study. , 2005, Archives of neurology.

[52]  K. Ishii,et al.  Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. , 2005, AJNR. American journal of neuroradiology.

[53]  S Minoshima,et al.  Cerebral glucose metabolism in patients with AD and different APOE genotypes , 2005, Neurology.

[54]  K Herholz,et al.  Metabolic interaction between ApoE genotype and onset age in Alzheimer’s disease: implications for brain reserve , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[55]  G. Frisoni,et al.  Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[56]  Holly Soares,et al.  Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele , 2004, Biological Psychiatry.

[57]  R. Petersen,et al.  Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy , 2004, Neurology.

[58]  B. Tycko,et al.  APOE-dependent PET patterns of brain activation in Alzheimer disease , 2004, Neurology.

[59]  C. Marra,et al.  Apolipoprotein E ε4 Allele Differently Affects the Patterns of Neuropsychological Presentation in Early- and Late-Onset Alzheimer’s Disease Patients , 2004, Dementia and Geriatric Cognitive Disorders.

[60]  Henrik Zetterberg,et al.  APOE ε4 allele is associated with reduced cerebrospinal fluid levels of Aβ42 , 2004, Neurology.

[61]  P. Zandi,et al.  Dementia: The leading predictor of death in a defined elderly population , 2004, Neurology.

[62]  W. Kukull,et al.  Survival after Initial Diagnosis of Alzheimer Disease , 2004, Annals of Internal Medicine.

[63]  M. Weiner,et al.  Cognition and anatomy in three variants of primary progressive aphasia , 2004, Annals of neurology.

[64]  A. Hofman,et al.  Apolipoprotein E genotype and concomitant clinical features in early-onset Alzheimer's disease , 2004, Journal of Neurology.

[65]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[66]  K. Blennow,et al.  CSF markers for incipient Alzheimer's disease , 2003, The Lancet Neurology.

[67]  M N Rossor,et al.  The prevalence and causes of dementia in people under the age of 65 years , 2003, Journal of neurology, neurosurgery, and psychiatry.

[68]  C. Holmes,et al.  Alzheimer’s disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia , 2003, Journal of neurology, neurosurgery, and psychiatry.

[69]  Tetsuya Mori,et al.  Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease , 2002, Journal of the Neurological Sciences.

[70]  J R Hodges,et al.  The prevalence of frontotemporal dementia , 2002, Neurology.

[71]  E. Bigio,et al.  Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis , 2002, Neuropathology and applied neurobiology.

[72]  M. Greicius,et al.  Presenile dementia syndromes: an update on taxonomy and diagnosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[73]  Frederik Barkhof,et al.  Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion , 2002, The Lancet Neurology.

[74]  M. Albert,et al.  Association between the APOE genotype and psychopathologic symptoms in Alzheimer’s disease , 2002, Neurology.

[75]  K. Ishii,et al.  The effect of APOE &egr;4 allele on cerebral glucose metabolism in AD is a function of age at onset , 2002, Neurology.

[76]  Hiroaki Kazui,et al.  Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease , 2001, Neurology.

[77]  D Commenges,et al.  Mortality with dementia: results from a French prospective community-based cohort. , 2001, American journal of epidemiology.

[78]  T D Bird,et al.  Neuropathological heterogeneity in Alzheimer’s disease: A study of 80 cases using principal components analysis , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.

[79]  K Patterson,et al.  Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. , 2000, Brain : a journal of neurology.

[80]  A. King,et al.  The question of familial meningiomas and schwannomas: , 2000, Neurology.

[81]  A. Hofman,et al.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[82]  A. Hofman,et al.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[83]  Charles DeCarli,et al.  APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.

[84]  C. Cotman,et al.  Clinical and pathological evidence for a frontal variant of Alzheimer disease. , 1999, Archives of neurology.

[85]  K. Blennow,et al.  Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. , 1999, Archives of neurology.

[86]  P. S. St George-Hyslop,et al.  Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. , 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[87]  G. Frisoni,et al.  Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.

[88]  J. Kessler,et al.  Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease , 1998, Neuroscience Letters.

[89]  K. Welsh-Bohmer,et al.  APOE genotype predicts when — not whether — one is predisposed to develop Alzheimer disease , 1998, Nature Genetics.

[90]  J. Kaye,et al.  High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. , 1998, Archives of neurology.

[91]  H. Möller,et al.  Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D. , 1998, Neurogenetics.

[92]  F. Yasuno,et al.  Age at Onset and Regional Cerebral Glucose Metabolism in Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[93]  Yaakov Stern,et al.  The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease , 1997, Annals of neurology.

[94]  J. Haines,et al.  ApoE-4 and Age at Onset of Alzheimer's Disease , 1997, Neurology.

[95]  K Patterson,et al.  Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[96]  H. Soininen,et al.  Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease , 1996, Neurology.

[97]  R. Mohs,et al.  Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease , 1996, Neurology.

[98]  C. Morris,et al.  Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians , 1995, Neuroscience Letters.

[99]  D. Clair,et al.  Apolipoprotein E Genotype and its Effect on Duration and Severity of Early and Late Onset Alzheimer's Disease , 1995, British Journal of Psychiatry.

[100]  B. Hyman,et al.  Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy , 1995 .

[101]  A D Roses,et al.  Apolipoprotein E and Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[102]  Giovanni B. Frisoni,et al.  Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late‐onset alzheimer's disease , 1995 .

[103]  R. Stelzmann,et al.  An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde” , 1995, Clinical anatomy.

[104]  M. Albert,et al.  Age at onset of Alzheimer's disease , 1994, Neurology.

[105]  R. Levy,et al.  Neuropathological Correlates of Psychotic Phenomena in Confirmed Alzheimer's Disease , 1994, British Journal of Psychiatry.

[106]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[107]  D. Kay,et al.  Clinically diagnosed presenile dementia of the Alzheimer type in the Northern Health Region: ascertainment, prevalence, incidence and survival , 1993, Psychological Medicine.

[108]  S. M. Sumi,et al.  Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease. , 1993, Alzheimer disease and associated disorders.

[109]  Benson Df,et al.  Posterior cortical atrophy. , 1988, Archives of neurology.

[110]  T J Rosen,et al.  Age at Onset and Rate of Progression of Alzheimer's Disease , 1987, Journal of the American Geriatrics Society.

[111]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[112]  L. Iversen,et al.  Neurochemical characteristics of early and late onset types of Alzheimer's disease. , 1984, British medical journal.

[113]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.